Home LiteratureArticle Details
PMID: 6997425 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.

The Journal of experimental medicine ·Vol. 152 ·No. 3 ·1980-09-01 ·Pages 657-73

Freedman VH, Calvelli TA, Silagi S, Silverstein SC

Abstract

We have demonstrated that a murine cytotoxic peritoneal cell can be elicited by intraperitoneal immunization with heat-killed Mycobacterium bovis, strain Bacillus Calmette-Guérin (BCG). When these cells are injected together with cells of clone B(5)59 of B16 melanoma in a Winn-type transfer assay into syngeneic C57BL/6J mice, the tumorigenic potential of the melanoma is completely abrogated. Similarly, mice immunized intraperitoneally with dead BCG are protected against intraperitoneal challenge with a number of B16 melanoma cells sufficient to cause tumors in 100% of control mice. However, mice immunized intraperitoneally with dead BCG are not protected against tumor formation when B16 melanoma cells are injected subcutaneously. Co-injection of BCG-elicited peritoneal cells with B16 melanoma cells into nude or sublethally irradiated (650 rad) mice inhibits tumor formation in > 85% of the mice, indicating that additional participation of host bone marrow- or thymus-derived leukocytes is not required to eradicate the tumor implant. The effector cell in the BCG-induced peritoneal exudate is adherent and phagocytic and is a mononuclear phagocyte. Nonadherent lymphoid cells from the same BCG-induced peritoneal exudate and from thioglycollate-broth-elicited granylocytes and macrophages neither prevent nor delay B16 tumor formation.

MeSH Terms
Animals Ascitic Fluid/cytology Cell Adhesion Cytotoxicity, Immunologic Immunotherapy Macrophages/immunology Melanoma/immunology,prevention & control Mice Mycobacterium bovis/immunology Neoplasm Transplantation Neoplasms, Experimental/prevention & control Phagocytosis
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Freedman V H
Calvelli T A
Silagi S
Silverstein S C
References (37)
37 references, click to expand
  1. Cellular kinetics associated with the development of acquired cellular resistance.
    J Exp Med. 1969 Aug 1;130(2):299-314 PMID: 4978533
  2. Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.
    J Cell Biol. 1969 Nov;43(2):263-74 PMID: 4981070
  3. Suppression of malignancy and differentiation in melanotic melanoma cells.
    Proc Natl Acad Sci U S A. 1970 May;66(1):72-8 PMID: 4921328
  4. In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages.
    Proc Soc Exp Biol Med. 1972 Mar;139(3):1049-52 PMID: 5023754
  5. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.
    J Natl Cancer Inst. 1972 May;48(5):1441-55 PMID: 4337912
  6. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis., 2. Comparative effects of vaccinia virus, oxazolone, and turpentine.
    J Natl Cancer Inst. 1972 Jun;48(6):1697-707 PMID: 4341404
  7. A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes.
    J Immunol. 1973 Mar;110(3):801-10 PMID: 4688920
  8. The interaction of particulate horseradish peroxidase (HRP)-anti HRP immune complexes with mouse peritoneal macrophages in vitro.
    J Cell Biol. 1972 Dec;55(3):616-34 PMID: 4656704
  9. Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects.
    In Vitro. 1971 Sep-Oct;7(2):105-14 PMID: 5170776
  10. Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.
    J Natl Cancer Inst. 1974 Jun;52(6):1887-95 PMID: 4857796
  11. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    J Natl Cancer Inst. 1974 Nov;53(5):1313-23 PMID: 4139279
  12. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    J Natl Cancer Inst. 1974 Nov;53(5):1325-31 PMID: 4139280
  13. Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.
    J Exp Med. 1975 Jun 1;141(6):1269-77 PMID: 1092796
  14. Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.
    J Exp Med. 1975 Jun 1;141(6):1278-90 PMID: 1127381
  15. Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells.
    J Natl Cancer Inst. 1975 May;54(5):1177-84 PMID: 1092874
  16. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
    Science. 1976 Jan 23;191(4224):299-301 PMID: 1108198
  17. Macrophage activation and anti-tumor activity of biologic and synthetic agents.
    Int J Cancer. 1976 Jan 15;17(1):82-9 PMID: 1248902
  18. Isolation of a subpopulation of adherent peritoneal cells with anti-tumour activity.
    Nature. 1976 Mar 11;260(5547):146-8 PMID: 768773
  19. An inhibitor of macrophage chemotaxis produced by neoplasms.
    Science. 1976 Apr 23;192(4237):370-2 PMID: 946556
  20. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Cancer Res. 1976 Dec;36(12):4459-66 PMID: 187324
  21. 2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect.
    J Exp Med. 1976 Dec 1;144(6):1465-83 PMID: 1032901
  22. Ionizing radiation and the immune response.
    Adv Immunol. 1976;24:215-335 PMID: 14486
  23. Decreased phagocytosis by peritoneal macrophages from BCG-treated mice: induction of the phagocytic defect in normal macrophages with BCG in vitro.
    Cell Immunol. 1977 Mar 15;29(2):295-311 PMID: 324633
  24. BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates.
    J Immunol. 1977 Sep;119(3):1152-8 PMID: 330750
  25. Biochemical and functional characteristics of the plasma membrane of macrophages from BCG-infected mice.
    J Immunol. 1978 May;120(5):1532-6 PMID: 351053
  26. The concept of the activated macrophage.
    J Immunol. 1978 Sep;121(3):806-9 PMID: 80431
  27. Activation of mononuclear phagocytes: fact, fancy, and future.
    J Immunol. 1978 Sep;121(3):813-6 PMID: 357655
  28. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.
    J Exp Med. 1979 Jan 1;149(1):100-13 PMID: 216763
  29. Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):5142-4 PMID: 283421
  30. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
    Gan. 1978 Dec;69(6):831-4 PMID: 374173
  31. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    J Immunol. 1979 Jul;123(1):350-7 PMID: 156233
  32. Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison.
    J Exp Med. 1980 Apr 1;151(4):969-74 PMID: 6445397
  33. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts.
    J Immunol. 1961 Feb;86:228-39 PMID: 13785862
  34. THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.
    J Exp Med. 1965 Jan 1;121:153-70 PMID: 14253481
  35. An analysis of the murine NK cell as to structure, function and biological relevance.
    Immunol Rev. 1979;44:165-208 PMID: 367949
  36. Natural killer cells: characteristics and regulation of activity.
    Immunol Rev. 1979;44:43-70 PMID: 761939
  37. Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets.
    Immunol Rev. 1979;44:71-123 PMID: 367950
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1980-09-01
Pages
657-73
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2185920
Subset
IM
Grants
NCI NIH HHS · 5F 32 CA 06201 · United States
NIAID NIH HHS · AI 08697 · United States
NCI NIH HHS · CA 10095 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com